Abdalhamid M Lagnf

1.4k total citations
43 papers, 937 citations indexed

About

Abdalhamid M Lagnf is a scholar working on Infectious Diseases, Clinical Biochemistry and Epidemiology. According to data from OpenAlex, Abdalhamid M Lagnf has authored 43 papers receiving a total of 937 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Infectious Diseases, 22 papers in Clinical Biochemistry and 17 papers in Epidemiology. Recurrent topics in Abdalhamid M Lagnf's work include Antimicrobial Resistance in Staphylococcus (24 papers), Bacterial Identification and Susceptibility Testing (22 papers) and Streptococcal Infections and Treatments (17 papers). Abdalhamid M Lagnf is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (24 papers), Bacterial Identification and Susceptibility Testing (22 papers) and Streptococcal Infections and Treatments (17 papers). Abdalhamid M Lagnf collaborates with scholars based in United States and Canada. Abdalhamid M Lagnf's co-authors include Michael J. Rybak, Susan L. Davis, Evan J Zasowski, Kimberly C. Claeys, Trang D Trinh, Sarah C J Jorgensen, Sahil Bhatia, Taylor Morrisette, Sara Alosaimy and Noor Sabagha and has published in prestigious journals such as Clinical Infectious Diseases, Antimicrobial Agents and Chemotherapy and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Abdalhamid M Lagnf

41 papers receiving 921 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Abdalhamid M Lagnf United States	18	468	366	343	317	307	43	937
Matthew G. Stilwell United States	15	457 1.0×	401 1.1×	327 1.0×	270 0.9×	334 1.1×	20	1.0k
William L. Musick United States	13	355 0.8×	339 0.9×	557 1.6×	476 1.5×	247 0.8×	24	1.1k
Molly E. Steed United States	18	650 1.4×	284 0.8×	363 1.1×	341 1.1×	315 1.0×	29	959
Twisha S Patel United States	16	214 0.5×	370 1.0×	257 0.7×	439 1.4×	257 0.8×	59	958
Jennifer S. McDanel United States	13	667 1.4×	187 0.5×	337 1.0×	357 1.1×	175 0.6×	25	1.1k
Michael P. Veve United States	17	305 0.7×	319 0.9×	124 0.4×	330 1.0×	272 0.9×	76	925
Carmen Betriú Spain	20	451 1.0×	323 0.9×	331 1.0×	406 1.3×	259 0.8×	55	1.1k
Katherine K. Perez United States	13	348 0.7×	229 0.6×	707 2.1×	457 1.4×	131 0.4×	27	1.2k
A. Evans United States	13	576 1.2×	185 0.5×	437 1.3×	223 0.7×	191 0.6×	15	882
Shawn H. MacVane United States	17	164 0.4×	517 1.4×	312 0.9×	426 1.3×	404 1.3×	34	977

Countries citing papers authored by Abdalhamid M Lagnf

Since Specialization

Citations

This map shows the geographic impact of Abdalhamid M Lagnf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abdalhamid M Lagnf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abdalhamid M Lagnf more than expected).

Fields of papers citing papers by Abdalhamid M Lagnf

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abdalhamid M Lagnf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abdalhamid M Lagnf. The network helps show where Abdalhamid M Lagnf may publish in the future.

Co-authorship network of co-authors of Abdalhamid M Lagnf

This figure shows the co-authorship network connecting the top 25 collaborators of Abdalhamid M Lagnf. A scholar is included among the top collaborators of Abdalhamid M Lagnf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abdalhamid M Lagnf. Abdalhamid M Lagnf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rebold, Nicholas, Abdalhamid M Lagnf, Sara Alosaimy, et al.. (2023). Risk Factors for Carbapenem-Resistant Enterobacterales Clinical Treatment Failure. Microbiology Spectrum. 11(1). e0264722–e0264722. 14 indexed citations

Morrisette, Taylor, Sara Alosaimy, Abdalhamid M Lagnf, et al.. (2022). Real-World, Multicenter Case Series of Patients Treated with Oral Omadacycline for Resistant Gram-Negative Pathogens. Infectious Diseases and Therapy. 11(4). 1715–1723. 12 indexed citations

Holger, Dana, Nicholas Rebold, Sara Alosaimy, et al.. (2022). Impact of Ceftolozane–Tazobactam vs. Best Alternative Therapy on Clinical Outcomes in Patients with Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa Lower Respiratory Tract Infections. Infectious Diseases and Therapy. 11(5). 1965–1980. 10 indexed citations

Rebold, Nicholas, Sara Alosaimy, Taylor Morrisette, et al.. (2022). Clinical Characteristics Associated with Bacterial Bloodstream Coinfection in COVID-19. Infectious Diseases and Therapy. 11(3). 1281–1296. 5 indexed citations

Lagnf, Abdalhamid M, et al.. (2022). Double antiglutamatergic treatment in patients with status epilepticus: A case series. Epilepsy & Behavior. 137(Pt A). 108954–108954.

Rebold, Nicholas, Taylor Morrisette, Abdalhamid M Lagnf, et al.. (2021). Early Multicenter Experience With Imipenem-Cilastatin-Relebactam for Multidrug-Resistant Gram-Negative Infections. Open Forum Infectious Diseases. 8(12). ofab554–ofab554. 24 indexed citations

Zasowski, Evan J, Trang D Trinh, Kimberly C. Claeys, et al.. (2021). Multicenter Cohort Study of Ceftaroline Versus Daptomycin for Treatment of Methicillin-Resistant Staphylococcus aureus Bloodstream Infection. Open Forum Infectious Diseases. 9(3). ofab606–ofab606. 18 indexed citations

Morrisette, Taylor, Abdalhamid M Lagnf, Sara Alosaimy, & Michael J. Rybak. (2020). A comparison of daptomycin alone and in combination with ceftaroline fosamil for methicillin-resistant Staphylococcus aureus bacteremia complicated by septic pulmonary emboli. European Journal of Clinical Microbiology & Infectious Diseases. 39(11). 2199–2203. 11 indexed citations

Alosaimy, Sara, Kyle C. Molina, Kimberly C. Claeys, et al.. (2020). Early Experience With Eravacycline for Complicated Infections. Open Forum Infectious Diseases. 7(5). ofaa071–ofaa071. 35 indexed citations

10.

Alosaimy, Sara, Noor Sabagha, Abdalhamid M Lagnf, et al.. (2020). Monotherapy with Vancomycin or Daptomycin versus Combination Therapy with β-Lactams in the Treatment of Methicillin-Resistant Staphylococcus Aureus Bloodstream Infections: A Retrospective Cohort Analysis. Infectious Diseases and Therapy. 9(2). 325–339. 23 indexed citations

11.

Jorgensen, Sarah C J, Kyle P. Murray, Abdalhamid M Lagnf, et al.. (2020). A Multicenter Evaluation of Vancomycin-Associated Acute Kidney Injury in Hospitalized Patients with Acute Bacterial Skin and Skin Structure Infections. Infectious Diseases and Therapy. 9(1). 89–106. 29 indexed citations

12.

Jorgensen, Sarah C J, Evan J Zasowski, Trang D Trinh, et al.. (2019). Daptomycin Plus β-Lactam Combination Therapy for Methicillin-resistant Staphylococcus aureus Bloodstream Infections: A Retrospective, Comparative Cohort Study. Clinical Infectious Diseases. 71(1). 1–10. 72 indexed citations

13.

Trinh, Trang D, Sarah C J Jorgensen, Evan J Zasowski, et al.. (2019). Multicenter Study of the Real-World Use of Ceftaroline versus Vancomycin for Acute Bacterial Skin and Skin Structure Infections. Antimicrobial Agents and Chemotherapy. 63(11). 4 indexed citations

14.

Jorgensen, Sarah C J, Abdalhamid M Lagnf, Sahil Bhatia, & Michael J. Rybak. (2019). A new simplified predictive model for mortality in methicillin-resistant Staphylococcus aureus bacteremia. European Journal of Clinical Microbiology & Infectious Diseases. 38(5). 843–850. 6 indexed citations

15.

Trinh, Trang D, Evan J Zasowski, Kimberly C. Claeys, et al.. (2018). Role of Vancomycin Minimum Inhibitory Concentrations by Modified Population Analysis Profile Method and Clinical Outcomes in High Inoculum Methicillin-Resistant Staphylococcus aureus Infections. Infectious Diseases and Therapy. 7(1). 161–169. 6 indexed citations

16.

Claeys, Kimberly C., Evan J Zasowski, Trang D Trinh, et al.. (2017). Antimicrobial Stewardship Opportunities in Critically Ill Patients with Gram-Negative Lower Respiratory Tract Infections: A Multicenter Cross-Sectional Analysis. Infectious Diseases and Therapy. 7(1). 135–146. 17 indexed citations

17.

Claeys, Kimberly C., Evan J Zasowski, Abdalhamid M Lagnf, et al.. (2017). Novel application of published risk factors for methicillin-resistant S. aureus in acute bacterial skin and skin structure infections. International Journal of Antimicrobial Agents. 51(1). 43–46. 12 indexed citations

18.

Trinh, Trang D, Evan J Zasowski, Kimberly C. Claeys, et al.. (2017). Multidrug-resistant Pseudomonas aeruginosa lower respiratory tract infections in the intensive care unit: Prevalence and risk factors. Diagnostic Microbiology and Infectious Disease. 89(1). 61–66. 30 indexed citations

19.

Zasowski, Evan J, Kimberly C. Claeys, Abdalhamid M Lagnf, Susan L. Davis, & Michael J. Rybak. (2016). Time Is of the Essence: The Impact of Delayed Antibiotic Therapy on Patient Outcomes in Hospital-Onset Enterococcal Bloodstream Infections. Clinical Infectious Diseases. 62(10). 1242–1250. 100 indexed citations

20.

Casapao, Anthony M., Susan L. Davis, John P. McRoberts, et al.. (2014). Evaluation of Vancomycin Population Susceptibility Analysis Profile as a Predictor of Outcomes for Patients with Infective Endocarditis Due to Methicillin-Resistant Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 58(8). 4636–4641. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact